Skip to content

Hormones in the plasma and milk of women in the first year postpartum: association with depressive symptoms and baby development

Adipocytokines in the plasma and breast milk of lactating mothers in the first year postpartum: association with depressive symptoms and cognitive and motor development of the infant

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-9hcby8c
Enrollment
Unknown
Registered
2023-12-19
Start date
2022-09-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Postpartum

Interventions

This is an observational prospective cohort study with four follow-up waves. The main exposure is the concentration of adipocytokines (adiponectin and leptin) in plasma and breast milk. Initially, pos
D06.472.699.042.249
D06.472.699.042.500
V03.175.500

Sponsors

Instituto Nacional de Saúde da Mulher da Criança e do Adolescente Fernandes Figueira/ Fundação Oswaldo Cruz
Lead Sponsor
Universidade Federal do Rio de Janeiro
Collaborator
Universidade Federal Fluminense
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Breastfeeding mothers up to 15 days postpartum; aged between 20 and 45 of age; exclusively breastfeeding (offering only breast milk without tea or water in the 5 days preceding entry into the study); be free from chronic non-communicable diseases such as high blood pressure and diabetes, except obesity; residing in the city of Rio de Janeiro; be free from infectious diseases such as HIV; proficient in the Portuguese language; and whose newborns had an Apgar score = 7 at the fifth minute

Exclusion criteria

Exclusion criteria: Breastfeeding mothers using antidepressant medication or other psychiatric medication; who had a twin pregnancy; who tested positive for Syphilis, Rubella, Toxoplasmosis, Cytomegalovirus, or Zika during pregnancy; who had gestational surrogacy/temporary uterine donation ('gestational carrier'); whose newborn had a premature birth, any pathology, inappropriate weight for gestational age, a diagnosis of any condition or malformation known to cause motor and/or cognitive deficits, or was admitted to a neonatal intensive care unit

Design outcomes

Primary

MeasureTime frame
Evaluate infant neurodevelopment using the Bayley Scales of Infant and Toddler Development III (Bayley-III), analyzed on a continuous scale;To assess postpartum depression, the Edinburgh Postnatal Depression Scale (EPDS) will be used, considering that women with a score equal to or greater than 13 are classified as having depressive symptoms

Secondary

MeasureTime frame
Assess maternal and infant body composition (weight, percentage of fat, percentage of lean mass) using plethysmography, analyzed continuously

Countries

Brazil

Contacts

Public ContactFernanda Rebelo

Instituto Nacional de Saúde da Mulher da Criança e do Adolescente Fernandes Figueira/ Fundação Oswaldo Cruz

frebelos@gmail.com+55(21)25541912

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 5, 2026